Actemra CAR-T-Related Indication Comes With Help From Novartis, Kite, US FDA

 
• By Sue Sutter
T-cells attacking cancer_1200x675
FDA approved Genentech's Actemra for treating CAR-T cell-related cytokine release syndrome

More from Approvals

More from Product Reviews